Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 11/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.44 |
| ▸ | DPP4 | P27487 | 3/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 3/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16412363 | 1.00 | GSR (0.47) | GSRDPP7DPP8DPP9DPP4 | |
| Hydrochloric Acid SCHEMBL20945373 | 0.98 | GSR (0.46) | GSRDPP7DPP8DPP9DPP4 | |
| SCHEMBL22690120 | 0.83 | DPP7 (0.40) | DPP7DPP8DPP9DPP4NOS2 | |
| SCHEMBL9989169 | 0.79 | GSR (0.53) | GSRDPP7DPP8DPP9DPP4 | |
| Urea SCHEMBL17442880 | 0.77 | GRM8 (0.46) | GSRDPP8DPP9DPP4CYP1A2 | |
| SCHEMBL1732378 | 0.75 | ALOX15 (0.32) | DPP7DPP8DPP9 | |
| SCHEMBL28841702 | 0.75 | PTGS1 (0.40) | — | |
| SCHEMBL31510395 | 0.74 | GSR (0.57) | GSRDPP7DPP8DPP9DPP4 | |
| SCHEMBL20240364 | 0.74 | GSR (0.61) | GSRDPP7DPP8DPP9DPP4 | |
| SCHEMBL28305389 | 0.74 | GSR (0.61) | GSRDPP7DPP8DPP9DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787877-B2 | Antibody with non-natural amino acid introduced therein | RIKEN (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20210107997-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | RIKEN (JP) | 2021-04-15 | — | — | US | disclosed |
| US-10906990-B2 | Antibody with non-natural amino acid introduced therein | RIKEN (JP) | 2021-02-02 | — | — | US | disclosed |
| US-20190127488-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | RIKEN (JP) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127488-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | NSUN3, NSUN2, LNPEP | GSR 4632/4885DPP7 2957/4885DPP8 2708/4885 |
| US-10906990-B2 | Antibody with non-natural amino acid introduced therein | NSUN3, NSUN2, LNPEP | GSR 4632/4885DPP7 2957/4885DPP8 2708/4885 |
| US-20210107997-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | NSUN3, NSUN2, LNPEP | GSR 4632/4885DPP7 2957/4885DPP8 2708/4885 |
| US-11787877-B2 | Antibody with non-natural amino acid introduced therein | NSUN3, NSUN2, LNPEP | GSR 4632/4885DPP7 2957/4885DPP8 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.